Tonix2.jpg
Tonix Pharmaceuticals Holdings Corp. Prices $40M Common Stock Offering Priced at-the-Market Under Nasdaq Rules
January 11, 2021 12:59 ET | Tonix Pharmaceuticals Holding Corp.
CHATHAM, N.J., Jan. 11, 2021 (GLOBE NEWSWIRE) -- TONIX PHARMACEUTICALS HOLDINGS CORP. (NASDAQ: TNXP) (“Tonix” or the “Company”), a clinical-stage biopharmaceutical company, today announced it has...
Tonix2.jpg
Tonix Pharmaceuticals to Participate in Upcoming January Conferences
January 05, 2021 16:15 ET | Tonix Pharmaceuticals Holding Corp.
CHATHAM, N.J., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth...
Tonix2.jpg
Tonix Pharmaceuticals and Massachusetts General Hospital (MGH) Enter into Research Collaboration on Tonix’s Third Generation anti-CD40-Ligand Monoclonal Antibody, TNX-1500, for the Treatment and Prevention of Kidney Transplant Rejection
January 05, 2021 07:00 ET | Tonix Pharmaceuticals Holding Corp.
Expands Ongoing Research Collaboration Between Tonix and MGH Studying TNX-1500 in Heart Transplantation TNX-1500 May Hold Potential in Treating Autoimmune Diseases Including Systemic Lupus...
Tonix2.jpg
Tonix Pharmaceuticals Plans Commercial Scale Vaccine Manufacturing Facility
December 23, 2020 09:00 ET | Tonix Pharmaceuticals Holding Corp.
Hamilton, MT Facility Is Planned to Manufacture Vaccines at Commercial Scale, Including Vaccines Under Development for COVID-19 CHATHAM, N.J., Dec. 23, 2020 (GLOBE NEWSWIRE) -- Tonix...
Tonix2.jpg
Tonix Pharmaceuticals Acquires Exclusive License to University of Geneva Technology for Oxytocin-Based Treatments for Treating Insulin Resistance, Diabetes and Obesity, Expanding Proprietary Uses for TNX-1900 (Intranasal Potentiated Oxytocin)
December 22, 2020 07:00 ET | Tonix Pharmaceuticals Holding Corp.
CHATHAM, N.J., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced an agreement...
Tonix2.jpg
Tonix Pharmaceuticals Reports Topline Results from Phase 3 RECOVERY Study of TNX-102 SL in PTSD and Outlines Future Development Plans
December 21, 2020 07:00 ET | Tonix Pharmaceuticals Holding Corp.
Primary Endpoint For Full Cohort of Enrolled Participants Did Not Achieve Statistical Significance (P=0.343), Consistent with Previously Reported Interim Analysis  Encouraging Activity of TNX-102 SL...
Tonix2.jpg
Tonix Pharmaceuticals Announces Positive Phase 3 RELIEF Study Results for TNX-102 SL 5.6 mg in Fibromyalgia
December 07, 2020 07:00 ET | Tonix Pharmaceuticals Holding Corp.
New 5.6 mg Dose Achieved Statistically Significant Pain Reduction Over Placebo at Week 14 (Primary Endpoint, p=0.01) TNX-102 SL Generally Well Tolerated with Adverse Event Profile Comparable to...
Tonix2.jpg
Vaccine Genome Researchers Report 99.7% Colinear Identity Between a U.S. Civil War Era Smallpox Vaccine and Horsepox Virus
December 04, 2020 08:00 ET | Tonix Pharmaceuticals Holding Corp.
Findings Published in the Current Issue of the Journal Genome Biology Horsepox is the Vector for Tonix’s Experimental TNX-1800 COVID-19 Vaccine Horsepox Has Been Used as a Smallpox Vaccine Since...
Tonix2.jpg
Tonix Pharmaceuticals Reports Positive Immune Response Results from COVID-19 Vaccine Candidate TNX-1800, Following Vaccination of Non-Human Primates
November 16, 2020 07:00 ET | Tonix Pharmaceuticals Holding Corp.
Anti-SARS-CoV-2 Neutralizing Antibodies Elicited in All Eight TNX-1800 Vaccinated Animals Skin Reaction or “Take,” a Validated Biomarker of Functional T cell Immunity, Elicited in All Eight TNX-1800...
Tonix2.jpg
Tonix Pharmaceuticals Outlines New Statistical Method to Analyze Future PTSD Studies at the 3rd Annual Neuropsychiatric Drug Development Summit
November 12, 2020 16:32 ET | Tonix Pharmaceuticals Holding Corp.
Increasing Placebo Responses in PTSD Drug Trials Raise Questions About Current Methods of Measuring or Analyzing PTSD Symptom Change Over Time The U.S. 21st Century Cures Act Provides Direction on...